Varian Medical Systems

Varian Medical Systems, headquartered globally in Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection.

Varian (VAR) continued to gain from core Oncology Systems segment in Q2.

Varian (VAR) Earnings and Revenues Surpass Estimates in Q2

Varian Medical Systems, Inc. (VAR) CEO Dow Wilson on Q2 2020 Results - Earnings Call Transcript

Varian's (VAR) solid Oncology platform is expected to have driven fiscal second-quarter performance.

What's in Store for Varian Medical (VAR) in Q2 Earnings?

The launch of this system is a step forward in Varian's (VAR) commitment toward strengthening its Proton Solutions segment.

Varian Unveils Proton Treatment Planning Eclipse v16 System

Varian's (VAR) flagship ProBeam platform is seeing multiple developments of late.

Varian's (VAR) ProBeam Compact Treats First Patient at UAB

Varian Medical (VAR) gains from solid prospects of its core Oncology Systems unit.

Here's Why You Should Hold Onto Varian Medical Stock Now

Varian (VAR) gains from core Oncology segment in fiscal Q1.

Varian (VAR) Earnings and Revenues Miss Estimates in Q1

Here's how the company beat revenue expectations but fell short on the bottom line.

What's Behind Varian Medical Systems' Mixed Q1 Results?

Varian Medical Systems, Inc. (VAR) CEO Dow Wilson on Fiscal Q1 2020 Results - Earnings Call Transcript

Demand for Eclipse and TrueBeam is expected to have driven Varian's (VAR) Oncology revenues in fiscal Q1.

What's in Store for Varian Medical (VAR) in Q1 Earnings?

Varian (VAR) gains from several positive developments.

Varian (VAR) Hits a 52-Week High: What's Driving the Stock?

Varian Medical Systems sees its Relative Strength Rating hit the 80-plus level.
The post Varian Medical Systems Clears Key Benchmark, Hitting 80-Plus RS Rating appeared first on Investor's Business Daily.

Varian Medical Systems Clears Key Benchmark, Hitting 80-Plus RS Rating

J.P. Morgan Alerian MLP Index ETN

ANSYS

Humana

International Flavors & Fragrances

Incyte

JPMorgan Chase & Co

Pentair

Vertex Pharmaceuticals

While value investors look for stocks that have become priced too low or high based on fundamental metrics such as earnings, revenue and debt, technical traders base their buys and sells off of recent trading action in a stock’s charts.

9 Most Overbought Stocks In The S&P 500

Diamondback Energy

Mondelez

Thursday's big stock charts focus on 3 names with a potential reversal ahead.
The post 3 Big Stock Charts for Thursday: Diamondback Energy, Mondelez, and Varian Medical appeared first on InvestorPlace.

3 Big Stock Charts for Thursday: Diamondback Energy, Mondelez, and Varian Medical

Varian Medical Systems sees its Relative Strength Rating enter the 80-plus level.
The post Stocks With Rising Relative Price Strength: Varian Medical Systems appeared first on Investor's Business Daily.

Stocks With Rising Relative Price Strength: Varian Medical Systems

American Express

CBRE Group

Deere & Company

Alphabet

Lowe's

MGM Resorts

Raytheon

Sempra Energy

Travelers

Goldman Sachs expects a tempered bull market to continue next year and provides a list of stocks that could outperform.

10 ‘Stellar’ Growth Stocks for a ‘Range-Bound’ Bull Market

Varian (VAR) gains from Oncology unit, deals with weakness in the Proton Therapy segment.

Here's Why You Should Hold on to Varian (VAR) Stock for Now

Varian's Moat May Be Worth Paying For (Podcast Transcript)

Varian Medical Systems (NYSE: VAR), a company that specializes in medical devices for radiation oncology treatments, has seen its stock price rise by 10% over the last month, driven in part by reasonably strong Q4 FY’19 results that were published in late October. (FY ends September).

Why Has Varian Medical Systems Stock Trended Higher Over The Last Month?

Varian's Moat May Be Worth Paying For (Podcast)

AmerisourceBergen

Abbott Labs

Cardinal Health

Penumbra

DENTSPLY SIRONA

Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.

Medical Products' Nov 7 Earnings Roster: ABC, CAH & More

Varian is targeting robust hardware opportunity in radiation therapy space.

Here's Why It Is Worth Buying Varian Medical Systems Stock Now

Varian Medical Systems, Inc. (VAR) CEO Dow Wilson on Q4 2019 Results - Earnings Call Transcript

Varian (VAR) is expected to have gained from core Proton Therapy platform in fiscal Q4.

What's in Store for Varian Medical (VAR) in Q4 Earnings?

Avinger

SPS Commerce

Skyworks Solutions

Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

News for Varian Medical Systems Stock (VAR)